Facial Synkinesis: Can It Have a Central Origin?
Objective: To describe a case of left facial synkinesis in a patient with a right middle cerebral artery stroke. Background: Facial synkinesis has been classically…Unraveling the Variability in Amantadine Response for Levodopa-Induced Dyskinesias: The Impact of Clinical and Genetic Factors
Objective: To identify demographic, clinical, and genetic factors associated with the outcomes of amantadine treatment in dyskinetic Parkinson’s disease (PD) patients. Background: While recent advancements…Movement Disorders in Autoimmune Encephalitis a Cohort
Objective: To analyze the clinical profile of patients with suspected autoimmune encephalitis. Background: Autoimmune encephalitis (AE) is a disease characterized by a diverse range of…Glossography – a novel, computer-vision based technique for assessing and treating involuntary tongue movements in dyskinetic episodes in Parkinson’s disease
Objective: To develop and evaluate a novel deep learning-based computer vision approach for tracking tongue movements in Parkinson's disease (PD) patients with levodopa-induced dyskinesias to…A Novel Dopaminergic Modulator (NDM-101) as an Adjunct to Levodopa: Enhancing Motor Control Without Worsening Dyskinesia in Parkinson’s Disease
Objective: To evaluate the efficacy and safety of NDM-101 as an adjunct to levodopa in reducing OFF-time, improving motor function, and maintaining quality of life…Plasma neurofilament light chain in early Parkinson’ s disease predicts motor complications: A Prospective Cohort Study
Objective: The current study aimed to identify risk plasma biomarkers in early-stage PD for future motor complications through a longitudinal Chinese PD cohort, which ultimately…Optimizing deep brain stimulation programming settings for patients with stimulation-induced dyskinesias in Parkinson’s disease
Objective: To assess the impact of Deep Brain Stimulation (DBS) parameters on stimulation-induced dyskinesias (SID) in patients with Parkison’s Disease (PD). Background: SID resemble levodopa-induced…Association Between Pesticide Exposure and Clinical Outcomes in Parkinson’s Disease: A Propensity-Matched Cohort Study
Objective: To evaluate the clinical outcomes associated with pesticide exposure in Parkinson’s disease (PD) participants in the Canadian Open Parkinson Network (COPN)(1). Background: Pesticide exposure…Foscarbidopa/Foslevodopa Therapy Improves Continuous Duration of Good ON Time and Correlated With Quality of Life in People With Parkinson’s Disease
Objective: To assess the impact of foscarbidopa/foslevodopa (CDp/LDp) continuous subcutaneous infusion (CSCI) on longest consecutive duration of Good and Best ON time and association of…Quality of Life Impact on Adults with Parkinson’s Disease Experiencing Morning Akinesia: Real-World Observational Findings
Objective: To compare the quality of life (QoL) in Parkinson’s Disease (PD) patients with and without morning akinesia (MA) in those using oral medications only…
- « Previous Page
- 1
- 2
- 3
- 4
- 5
- …
- 44
- Next Page »